Skip to main content
Advanced Technical IVT

hyperviscosity syndrome

A clinical condition caused by increased blood viscosity, typically due to elevated protein levels or increased cellular components.

Full Definition

Hyperviscosity syndrome occurs when blood becomes abnormally thick due to increased protein concentration (particularly immunoglobulins) or excessive cellular elements, leading to impaired circulation and end-organ dysfunction. In hematologic malignancies, this syndrome is most commonly associated with Waldenström macroglobulinemia, multiple myeloma, and polycythemia vera. Clinical manifestations include neurological symptoms (headache, confusion, visual disturbances), bleeding tendencies despite normal platelet counts, and cardiovascular compromise. Treatment involves addressing the underlying cause and may require emergency plasmapheresis or phlebotomy to rapidly reduce viscosity.

Usage

Usage note: Should be distinguished from other microangiopathic conditions that may present with similar neurological symptoms.

In Context

  • "The patient's visual symptoms and elevated serum viscosity confirmed hyperviscosity syndrome." — Clinical assessment
  • "Emergency plasmapheresis was performed to treat hyperviscosity syndrome secondary to Waldenström macroglobulinemia." — Treatment record

Also known as

blood hyperviscosity serum hyperviscosity

Don't confuse with

thrombotic thrombocytopenic purpura hemolytic uremic syndrome

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON